These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11711782)

  • 21. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study.
    Chan FK; Sung JJ; Suen R; Lee YT; Wu JC; Leung WK; Chan HL; Lai AC; Lau JY; Ng EK; Chung SC
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1201-5. PubMed ID: 9882027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
    Kaviani MJ; Malekzadeh R; Vahedi H; Sotoudeh M; Kamalian N; Amini M; Massarrat S
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):915-9. PubMed ID: 11507355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
    Carpintero P; Blanco M; Pajares JM
    Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea.
    Chung KH; Lee DH; Jin E; Cho Y; Seo JY; Kim N; Jeong SH; Kim JW; Hwang JH; Shin CM
    Gut Liver; 2014 Nov; 8(6):605-11. PubMed ID: 25368747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
    Calvet X; Ducons J; Guardiola J; Tito L; Andreu V; Bory F; Guirao R;
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1261-7. PubMed ID: 12144575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Six-year follow-up after Helicobacter pylori eradication in peptic ulcer disease.
    O'Connor HJ; Stewart C; Walsh R; McGee CN; Flynn B
    Ir J Med Sci; 2001; 170(1):24-7. PubMed ID: 11440407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
    Wong BC; Lam SK; Lai KC; Hu WH; Ching CK; Ho J; Yuen ST; Chan CK; Lau GK; Lai CL
    Aliment Pharmacol Ther; 1999 Mar; 13(3):303-9. PubMed ID: 10102962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
    de Boer WA; Driessen WM; Jansz AR; Tytgat GN
    Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1189-94. PubMed ID: 8789310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
    Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
    Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it.
    Gisbert JP; Pajares JM; García-Valriberas R; Abraira V; Boixeda D; García-Grávalos R; Martín-de-Argila C; García-Plaza A
    Scand J Gastroenterol; 1998 Nov; 33(11):1144-51. PubMed ID: 9867091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical issues in the pathophysiology and management of peptic ulcer disease.
    Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea.
    Cheon JH; Kim N; Lee DH; Kim JM; Kim JS; Jung HC; Song IS
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):515-9. PubMed ID: 16607147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
    Soll AH
    JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
    Archimandritis A; Balatsos V; Delis V; Mentis A; Kastanas K; Scandalis N
    J Clin Gastroenterol; 1995 Jan; 20(1):12-6. PubMed ID: 7884169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.